The global mammography market size was valued at USD 1.43 billion in 2015 and is projected to grow at a CAGR of 10.5% during the forecast period. The market is experiencing growth due to rising breast cancer cases and growing awareness pertaining to preventive checkup for breast cancer.
U.S. mammography market, by product, 2013 - 2025 (USD Million)
The rising healthcare expenditure, booming healthcare industry, and growing demand for regular monitoring are some of the pivotal factors expected to propel demand for mammography equipment in the coming years. Growing government initiatives to improve clinical interpretation and increase access to mammary gland cancer screening systems is one of the crucial factors expected to drive the demand over the forecast period.
In addition to these initiatives, the Health Resources and Services Administration (HRSA) had introduced Federal Consolidated Health Centers Programs to increase the screening procedures in medically underserved areas. Under Governor Cuomo, the New York State is improving access to early breast cancer screening. The abovementioned initiatives are for supporting patients with family income below the federal level.
Digital systems segment held the 62.1% of the revenue share in 2015. The growing demand for technologically advanced breast cancer screening and diagnostic equipment is one of the crucial factors expected to drive the market in the coming years. The presence of favorable reimbursement policies and growing government support in improving screening results are some of the key attributes that account for the largest revenue share of the global mammography market.
However, 3D mammography system market is the fastest growing product segment with a CAGR of 13.1% during 2016 to 2025. The presence of the Medical Imaging Modernization Act, 2015, is one of the pivotal factors up surging the demand for 3D systems in the coming years. The rising demand for highly specific screening equipment to reduce call-back visits, false alarm, and missed cancer diagnosis is also one of the main factors contributing to the up surging demand.
Digital mammography technology held approximately 69.3% share in 2015. Rapidly changing technology is one of the key factors enhancing the adoption and utilization of digital mammography devices. The technological advancements in hybrid imaging with mammography, such as CAD with mammography & X-ray imaging with mammography and growing product approval in this segment are some of the attributes that account for the largest market size.
However, breast tomosynthesis is yet to exhibit growth with an approximate CAGR of 13.4% in the coming few years. In the recent years, breast tomosynthesis has become the biggest technological development in mammography.
Global mammography market, by technology, 2015 (USD Million)
This technology was first launched in Europe in 2008 by Hologic, Inc. The product was approved for sales in 2011 in the U.S. market. The growing demand for technologically advanced techniques with improved cancer detection and diagnostic sensitivity is one of the key attributes representing the potential market growth over the forecast period.
North America held the majority of the share of about 42.8% in 2015. The region suffers from a burden of rising breast cancer cases and increasing women population of above 40 years.
North America has sophisticated healthcare facilities, and the reimbursement coverage contributes to the large share of the region. Moreover, increasing number of mammography units in the hospitals & diagnostic centers and number of units per million women population in the U.S. is also expected to drive the market.
Asia Pacific is projected to be the fastest growing market with a CAGR of 13.5% during the forecast period. The emerging economies, such as India and China, in the region are lucrative markets due to the dynamic change in the lifestyle of the urban part of the countries, which is leading to high prevalence of breast cancer. The local presence of significant players such as Hologic, Fujifilm, Philips Healthcare is one of the crucial factors further expected to boost the market in the coming years.
Some of the major companies are Fujifilm; Hologic; Phillips Healthcare; Siemens Healthcare; Toshiba Medical Systems, Metaltronica; GE Healthcare; and I.M.S. Srl. Hologic has a wide product portfolio, which includes digital mammography, breast tomosynthesis technology, computer-aided detection, and other breast biopsy devices. Based on the investor presentations, it was stated that Hologic holds approximately 50% of the total market share of market.
Report Attribute |
Details |
Market size value in 2020 |
USD 2.36 billion |
Revenue forecast in 2025 |
USD 3.8 billion |
Growth Rate |
CAGR of 10.5% from 2016 to 2025 |
Base year for estimation |
2015 |
Historical data |
2014 - 2015 |
Forecast period |
2016 - 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2016 to 2025 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product type, application, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; UK; Germany; Japan; China; India; Brazil; Mexico; South Africa |
Key companies profiled |
Hologic; Fujifilm; Siemens Healthcare; Phillips Healthcare; Toshiba Medical Systems, GE Healthcare; Metaltronica; I.M.S. Srl |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth and provides an analysis on the industry trends in each of the sub-segments from 2013 to 2025. For the purpose of this study, Grand View Research has segmented the global mammography market on the basis of product type, application, and region:
Product Outlook (Revenue, USD Million; 2013 - 2025)
Film Screen Systems
Digital Systems
Analog Systems
Biopsy Systems
3D Systems
Technology Outlook (Revenue, USD Million; 2013 - 2025)
Breast Tomosynthesis
CAD
Digital
Regional Outlook (Revenue, USD Million; 2013 - 2025)
North America
U.S.
Canada
Europe
Germany
UK
Asia Pacific
China
Japan
Latin America
Mexico
Brazil
MEA
South Africa
b. The global mammography market size was estimated at USD 2.11 billion in 2019 and is expected to reach USD 2.36 billion in 2020.
b. The global mammography market is expected to grow at a compound annual growth rate of 10.5% from 2017 to 2025 to reach USD 3.83 billion by 2025.
b. North America dominated the mammography market with a share of 40.5% in 2019. This is attributable to rising growing prevalence of breast cancer and an increase in women population of above 40 years.
b. Some key players operating in the mammography market include Hologic; Fujifilm; Siemens Healthcare; Phillips Healthcare; Toshiba Medical Systems, GE Healthcare; Metaltronica; and I.M.S. Srl.
b. Key factors that are driving the market growth include rising prevalence of breast cancer, favorable government initiatives, and technological advancements.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.